Pancreatic exocrine function in patients with diabetes

Diabetic Medicine

Volumn 29, Issue 8, 2012, Pages 1047-1054

  Larger, E ^a   Philippe, M F ^a   Barbot Trystram, L ^b   Radu, A ^a   Rotariu, M ^a   Nobecourt E ^a   Boitard, C ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Angiopathies; Chymotrypsin activity; Diabetes; Elastase 1; Exocrine pancreas

Indexed keywords

CHYMOTRYPSIN; GLUTAMATE DECARBOXYLASE ANTIBODY; HEMOGLOBIN A1C; INSULIN; PANCREATIC ELASTASE;

ADULT; AGED; ALBUMINURIA; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; ENZYME ACTIVITY; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS FUNCTION; PANCREAS FUNCTION DISORDER; PREVALENCE; VASCULAR DISEASE;

ADULT; AGED; ANTIBODIES; BODY MASS INDEX; CHYMOTRYPSIN; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; EXOCRINE PANCREATIC INSUFFICIENCY; FECES; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; MIDDLE AGED; PANCREAS, EXOCRINE; PANCREATIC ELASTASE;

EID: 84864010108     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03597.x     Document Type: Article

References (30)

1. Vacca J, Henke W, Knight W. The exocrine pancreas in diabetes mellitus. Ann Intern Med 1964; 61: 242-247.
2. Hardt PD, Brendel MD, Kloer HU, Bretzel RG. Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed? Diabetes Care 2008; 31(Suppl 2): S165-S169.
3. Andren-Sandberg A, Hardt PD. Second Giessen International Workshop on Interactions of Exocrine and Endocrine Pancreatic Diseases. Castle of Rauischholzhausen of the Justus-Liebig-university, Giessen (Rauischholzhausen), Germany. March 7-8, 2008. JOP 2008; 9: 541-575.
4. Keller J, Aghdassi A, Lerch M, Mayerle J. Tests of pancreatic function - clinical significance in pancreatic and non-pancreatic disorders. Best Pract Res Clin Gastroenterol 2009; 23: 425-439.
5. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34(Suppl 1): S62-S69.
6. Cecil RL. A study of the pathological anatomy of the pancreas in ninety cases of diabetes mellitus. J Exp Med 1909; 11: 266-290.
7. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14: 619-633.
8. Lohr M, Kloppel G. Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 1987; 30: 757-762.
9. Volk BW, Wellmann KF. Idiopathic diabetes. In: Volk BW, Wellmann KF, eds. The Diabetic Pancreas. New York: Plenum Press 1977; 230-260.
10. Philippe MF, Benabadji S, Barbot-Trystram L, Vadrot D, Boitard C, Larger E. Pancreatic volume and endocrine and exocrine functions in patients with diabetes. Pancreas 2011; 40: 359-363.
11. Hardt PD, Hauenschild A, Nalop J, Marzeion AM, Jaeger C, Teichmann J et al. High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1, 021 diabetic patients. Pancreatology 2003; 3: 395-402.
12. Cavalot F, Bonomo K, Perna P, Bacillo E, Salacone P, Gallo M et al. Pancreatic elastase-1 in stools, a marker of exocrine pancreas function, correlates with both residual beta-cell secretion and metabolic control in type 1 diabetic subjects. Diabetes Care 2004; 27: 2052-2054.
13. Creutzfeldt W, Gleichmann D, Otto J, Stockmann F, Maisonneuve P, Lankisch PG. Follow-up of exocrine pancreatic function in type-1 diabetes mellitus. Digestion 2005; 72: 71-75.
14. Ewald N, Raspe A, Kaufman C, Bretzel RG, Kloer HU, Hardt PD. Determinants of exocrine pancreatic function as measured by fecal elastase-1 concentration in patients with diabetes mellitus. Eur J Med Res 2009; 14: 118-122.
15. Lankisch PG. Secretion and absorption (methods and functions). Best Pract Res Clin Gastroenterol 2009; 23: 325-335.
16. Lieb JG 2nd, Draganov PV. Pancreatic function testing: here to stay for the 21st century. World J Gastroenterol 2008; 14: 3149-3158.
17. Hahn JU, Kerner W, Maisonneuve P, Lowenfels AB, Lankisch PG. Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus. Pancreas 2008; 36: 274-278.
18. Hardt PD. Comment on 'Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus (pancreas. 2008; 36: 274-278)'. Pancreas 2009; 38: 471-472 author reply 472-473.
19. Cavalot F, Bonomo K, Fiora E, Bacillo E, Salacone P, Chirio M et al. Does pancreatic elastase-1 in stools predict steatorrhea in type 1 diabetes? Diabetes Care 2006; 29: 719-721.
20. Hardt PD, Krauss A, Bretz L, Porsch-Ozcurumez M, Schnell-Kretschmer H, Maser E et al. Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitus. Acta Diabetol 2000; 37: 105-110.
21. Lankisch PG, Manthey G, Otto J, Koop H, Talaulicar M, Willms B et al. Exocrine pancreatic function in insulin-dependent diabetes mellitus. Digestion 1982; 25: 211-216.
22. Herzig K-H, Purhonen A-K, Rasanen K, Idziak J, Juvonen P, Phillps R et al. Fecal pancreatic elastase-1 levels in older individuals without known gastrointestinal diseases or diabetes mellitus. BMC Geriatrics 2011; 11: 4.
23. Imagawa A, Hanafusa T, Tamura S, Moriwaki M, Itoh N, Yamamoto K et al. Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity. Diabetes 2001; 50: 1269-1273.
24. Mossner J, Logsdon CD, Williams JA, Goldfine ID. Insulin, via its own receptor, regulates growth and amylase synthesis in pancreatic acinar AR42J cells. Diabetes 1985; 34: 891-897.
25. Czako L, Hegyi P, Rakonczay JZ, Wittmann T, Otsuki M. Interactions between the endocrine and exocrine pancreas and their clinical relevance. Pancreatology 2009; 9: 351-359.
26. Pollak OJ. Human pancreatic atherosclerosis. Ann N Y Acad Sci 1968; 149: 928-939.
27. Panicot L, Mas E, Thivolet C, Lombardo D. Circulating antibodies against an exocrine pancreatic enzyme in type 1 diabetes. Diabetes 1999; 48: 2316-2323.
28. Hardt PD, Ewald N, Brockling K, Tanaka S, Endo T, Kloer HU et al. Distinct autoantibodies against exocrine pancreatic antigens in European patients with type 1 diabetes mellitus and non-alcoholic chronic pancreatitis. JOP 2008; 9: 683-689.
29. Tridgell DM, Spiekerman C, Wang RS, Greenbaum CJ. Interaction of onset and duration of diabetes on the percent of GAD and IA-2 antibody-positive subjects in the type 1 diabetes genetics consortium database. Diabetes Care 2011; 34: 988-993.
30. Kauppila LI, Hekali P, Penttila A. Postmortem pancreatic angiography in 45 subjects with non-insulin-dependent diabetes mellitus and 51 controls. Pancreas 1998; 16: 60-65.